T1	SNP 82 92	rs11249433
T2	Entity 76 80	1p11
R1	SNP_location Arg1:T1 Arg2:T2	
T3	Association 10 22	interactions
E1	Association:T3 snp_int:T1 bc:T4
T4	Cancer 98 140	hormone receptor status with breast cancer
A1	Cancer_Type T4 Molec_Status_other
T5	Spec 0 9	Assessing
R2	Speculation_marker Arg1:E1 Arg2:T5	
T6	SNP 171 181	rs11249433
T7	Entity 198 202	1p11
R3	SNP_location Arg1:T6 Arg2:T7	
T8	Association 151 162	association
E2	Association:T8 snp_int:T6 bc:T9
T9	Cancer 207 220	breast cancer
T10	Cancer 222 224	BC
R4	Equiv Arg1:T10 Arg2:T9	
T11	Spec 242 251	evaluated
R5	Speculation_marker Arg1:E2 Arg2:T11	
T12	Spec 372 383	investigate
T13	Association 475 487	relationship
E3	Association:T13 snp_int:T15 bc:T16
R6	Speculation_marker Arg1:E3 Arg2:T12	
T14	Entity 500 504	1p11
T15	SNP 505 515	rs11249433
T16	Cancer 533 535	BC
R7	SNP_location Arg1:T15 Arg2:T14	
T17	Association 971 992	per-allele odds ratio
E4	Association:T17 snp_int:T20 bc:T18
T18	Cancer 1002 1004	BC
T19	Entity 1008 1012	1p11
T20	SNP 1013 1023	rs11249433
R8	SNP_location Arg1:T20 Arg2:T19	
T21	Entity 1127 1135;1150 1164	dominant genetic models
T22	Entity 1140 1164	recessive genetic models
R9	Genotype Arg1:T20 Arg2:T22	
R10	Genotype Arg1:T20 Arg2:T21	
T23	Level 1077 1088	Significant
T24	Association 1089 1101	associations
E5	Association:T24 snp_int:T20 bc:T18
A2	Level E5 High
R11	Equiv Arg1:E5 Arg2:E4	
R12	Level_marker Arg1:E5 Arg2:T23	
T25	Level 1205 1218	significantly
T26	Effect_Type 1219 1228	increased
T27	Association 1229 1234	risks
E6	Association:T27 bc:T18 snp_int:T34
A3	Effect_Type E6 Increase
A4	Level E6 High
T28	Entity 1249 1259	Caucasians
T29	Entity 1314 1320	Asians
T30	Entity 1325 1333	Africans
T31	Level 1269 1283	no significant
T32	Association 1284 1296	associations
E7	Association:T32 bc:T18 snp_int:T33
A5	Level E7 Low
R13	Level_marker Arg1:E7 Arg2:T31	
R14	Effect_type_marker Arg1:E6 Arg2:T26	
R15	Level_marker Arg1:E6 Arg2:T25	
T33	SNP 1013 1023	rs11249433
T34	SNP 1013 1023	rs11249433
R16	Population_assignment Arg1:T34 Arg2:T28	
R17	Population_assignment Arg1:T33 Arg2:T29	
R18	Population_assignment Arg1:T33 Arg2:T30	
R19	SNP_location Arg1:T34 Arg2:T19	
R20	SNP_location Arg1:T33 Arg2:T19	
T35	Entity 1371 1375	1p11
T36	SNP 1376 1386	rs11249433
R21	SNP_location Arg1:T36 Arg2:T35	
T37	Spec 1357 1365	indicate
T38	Association 1403 1411	involved
E8	Association:T38 snp_int:T36 bc:T39
R22	Speculation_marker Arg1:E8 Arg2:T37	
T39	Cancer 1415 1417	BC
T40	Effect_Type 1486 1494	positive
T41	Organic_inorganic_molecules_affected 1448 1454	effect
E9	Organic_inorganic_molecules_affected:T41 Agent:T36 Theme:T42 Theme2:T43
R23	Effect_type_marker Arg1:E9 Arg2:T40	
A6	Effect_Type E9 Increase
T42	Entity 1468 1485	estrogen receptor
T43	Entity 1499 1520	progesterone receptor
T44	Cancer 1468 1536	estrogen receptor-positive and progesterone receptor-positive tumors
A7	Cancer_Type T44 Horm+ve_other
T45	Association 1448 1454	effect
E10	Association:T45 snp_int:T36 bc:T44
A8	Level E10 High
T46	Level 1455 1464	primarily
R24	Level_marker Arg1:E10 Arg2:T46	
T47	Entity 1594 1602	G allele
T48	Entity 1606 1610	1p11
T49	SNP 1611 1621	rs11249433
R26	SNP_location Arg1:T49 Arg2:T48	
R27	SNP_allele Arg1:T49 Arg2:T47	
T50	Association 1639 1649	associated
E11	Association:T50 snp_int:T49 bc:T52
T51	Effect_Type 1655 1664	increased
A9	Effect_Type E11 Increase
R28	Effect_type_marker Arg1:E11 Arg2:T51	
T52	Cancer 1665 1678	breast cancer
